These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15551171)

  • 41. Psoriasis: an evidence-based update. Report of the 9th evidenced based update meeting, 12 May 2011, Loughborough, UK.
    De Mozzi P; Johnston GA; Alexandroff AB
    Br J Dermatol; 2012 Feb; 166(2):252-60. PubMed ID: 22268857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Biologics in skin diseases other than psoriasis].
    Gniadecki R; Skov L
    Ugeskr Laeger; 2008 Jun; 170(24):2126-8. PubMed ID: 18565293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinically significant therapeutic interactions for the practicing dermatologist.
    Lebwohl M; Gelfand JM; Tan MH
    Adv Dermatol; 1999; 14():1-26; discussion 27. PubMed ID: 10643493
    [No Abstract]   [Full Text] [Related]  

  • 44. Solcoderm.
    Dermatologica; 1984; 168 Suppl 1():5-65. PubMed ID: 6468721
    [No Abstract]   [Full Text] [Related]  

  • 45. Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.
    Loewe R; Pillinger M; de Martin R; Mrowietz U; Gröger M; Holnthoner W; Wolff K; Wiegrebe W; Jirovsky D; Petzelbauer P
    J Invest Dermatol; 2001 Dec; 117(6):1363-8. PubMed ID: 11886496
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical retinoids and cutaneous biology.
    Craven NM; Griffiths CE
    Clin Exp Dermatol; 1996 Jan; 21(1):1-10. PubMed ID: 8689759
    [No Abstract]   [Full Text] [Related]  

  • 47. Defining Outcome Measures for Psoriasis: The IDEOM Report from the GRAPPA 2016 Annual Meeting.
    Callis Duffin K; Gottlieb AB; Merola JF; Latella J; Garg A; Armstrong AW
    J Rheumatol; 2017 May; 44(5):701-702. PubMed ID: 28461532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Alginates as keratolytic agents in local dermatological therapy].
    De Luca M
    Minerva Dermatol; 1968 Mar; 43(3):135-7. PubMed ID: 5740427
    [No Abstract]   [Full Text] [Related]  

  • 49. [Medical tumor therapy].
    Becker JC; Gutzmer R; Mauch C
    Hautarzt; 2011 Jun; 62(6):412-3. PubMed ID: 21656112
    [No Abstract]   [Full Text] [Related]  

  • 50. Polyphenotypic Psoriasis: A Report from the GRAPPA 2016 Annual Meeting.
    Kaskas N; Merola JF; Qureshi AA; Paek SY
    J Rheumatol; 2017 May; 44(5):695-696. PubMed ID: 28461530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanisms of tazarotene action in psoriasis.
    Duvic M; Nagpal S; Asano AT; Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S18-24. PubMed ID: 9270552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psoriasis Therapy: Breakthroughs in Pharmacogenomics or in Pharmacology?
    Lebwohl M
    J Invest Dermatol; 2016 Dec; 136(12):2339-2340. PubMed ID: 27884289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor necrosis factor (TNF) inhibitors revolutionalized therapy for both psoriasis and psoriatic arthritis. Foreword.
    Gottlieb AB
    Am J Clin Dermatol; 2014 Feb; 15 Suppl 1():S3-4. PubMed ID: 24777570
    [No Abstract]   [Full Text] [Related]  

  • 54. [What's new in dermatological research? Contributions from the 2006 literature].
    Caux F
    Ann Dermatol Venereol; 2007 Dec; 134 Suppl 1():8S16-23. PubMed ID: 18675137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of mycophenolate mofetil therapy on the phenotypic profile of peripheral blood leukocyte populations in psoriatic patients.
    Daudén E; Pedraz J; Pérez-Gala S; Muñoz C; Vitón M; Onate MJ; García-Díez A
    Eur J Dermatol; 2010; 20(2):233-4. PubMed ID: 20007061
    [No Abstract]   [Full Text] [Related]  

  • 56. Pimecrolimus for psoriasis.
    Ayer J; Young HS
    Expert Opin Pharmacother; 2013 Apr; 14(6):767-74. PubMed ID: 23461536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dermatology--new therapeutic possibilities. The Danish Society of Dermatology].
    Gniadecki R; Haedersdal M
    Ugeskr Laeger; 2006 Mar; 168(12):1213. PubMed ID: 16571304
    [No Abstract]   [Full Text] [Related]  

  • 58. Methotrexate: new therapeutic approaches.
    Puig L
    Actas Dermosifiliogr; 2014; 105(6):583-9. PubMed ID: 23434058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [How I treat...topical treatment of plaque type psoriasis by the combination of calcipotriol and betamethasone dipropionate].
    Henry F; Flagothier C; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2006 Mar; 61(3):139-41. PubMed ID: 16680996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zinc finger protein A20 is involved in the antipsoriatic effect of calcipotriol.
    Liu X; Liu Y; Xu M; Li J; Teng X; Cheng H; Xia Y
    Br J Dermatol; 2016 Aug; 175(2):314-24. PubMed ID: 26875609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.